-

Shareholder Alert: Robbins LLP Reminds Investors It Is Investigating World Wrestling Entertainment, Inc. (WWE) for Misleading Shareholders

SAN DIEGO & STAMFORD, Conn.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that it is investigating World Wrestling Entertainment, Inc. (NYSE: WWE) for alleged violations of the Securities Exchange Act of 1934 and whether the Company's officers and directors breached their fiduciary duties to shareholders. WWE is an integrated media and entertainment company that engages in the sports entertainment business.

If you suffered a loss as a result of WWE's misconduct, click here.

World Wrestling Entertainment, Inc. (WWE) Loses Saudi Media Rights Deal

In recent years, WWE had entered into a multiyear television distribution rights agreement with Saudi-controlled Orbit Showcase Network ("OSN") and a partnership with the Saudi General Sports Authority to host live events in Saudi Arabia. However ideological differences between the Company and the Saudi government led to the Saudi government's refusal to pay millions of dollars it owed to WWE and OSN's early termination of its agreement with WWE. As a result, on February 6, 2020, WWE disclosed its disappointing financial performance due to its inability to secure a favorable broadcasting deal with the Saudi government, revealing that the Saudi media rights deal was no longer part of WWE's financial forecast. Following all of its disclosures, WWE's stock traded as low as $32.38 on March 12, 2020, representing a staggering 67% decline from its class period high of more than $100.

World Wrestling Entertainment, Inc. (WWE) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:WWE

Release Versions
$Cashtags

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Robbins LLP Reminds LAKE Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Lakeland Industries, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Lakeland Industries, Inc. (NASDAQ: LAKE) securities between December 1, 2023 and December 9, 2025. Lakeland, together with its subsidiaries, manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide.For more information, submit a form, email attorney Aaron Dumas, Jr....

Investor Notice: Robbins LLP Informs Investors of the New Era Energy & Digital, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired New Era Energy & Digital, Inc. (NASDAQ: NUAI) securities between November 6, 2024 and December 29, 2025. New Era Energy, formerly known as New Era Helium (NASDAQ: NEHC), is an oil and natural gas company.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Robbins LLP is...

Investor Notice: Robbins LLP Informs Investors of the Gossamer Bio, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gossamer Bio, Inc. (NASDAQ: GOSS) securities between June 16, 2025 and February 20, 2026. Gossamer is a clinical stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension (PH) associated with interstitial lung disease. For more information, submit a form, email a...
Back to Newsroom